Company Filing History:
Years Active: 2013
Title: Mary Ellen Maddalena: Innovator in Prostate Cancer Treatment
Introduction
Mary Ellen Maddalena is a notable inventor based in Monmouth Junction, NJ (US). She has made significant contributions to the field of medical research, particularly in the treatment of prostate cancer. Her innovative work has led to the development of novel methods aimed at improving patient outcomes.
Latest Patents
Mary Ellen Maddalena holds 1 patent for her invention related to gastrin releasing peptide compounds. This patent outlines methods for treating prostate tumors and delaying their progression. The methods include treating bone or soft tissue metastases of prostate cancer, addressing both hormone-sensitive and hormone-refractory prostate cancer. The invention also facilitates combination therapy in patients with hormone-sensitive prostate cancer and aims to decrease aberrant vascular permeability in these patients. The administration of a specific dose comprising radioactively labeled compounds is a key aspect of her innovative approach.
Career Highlights
Maddalena's career is marked by her dedication to advancing cancer treatment methodologies. Her work at Bracco Imaging S.p.a. has positioned her as a leader in the field. She has focused on developing effective therapeutic strategies that can significantly impact patient care.
Collaborations
Throughout her career, Mary Ellen Maddalena has collaborated with esteemed colleagues, including Enrico Cappelletti and Luciano Lattuada. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Mary Ellen Maddalena's contributions to prostate cancer treatment exemplify her commitment to medical innovation. Her patented methods offer hope for improved therapies in the fight against cancer.